Biotricity

83 articles with Biotricity

• Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor

  11/10/2021

  Biotricity, Inc. (NASDAQ:BTCY), a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions, today announced the availability of Bioheart, a direct-to-consumer heart monitor that offers the same continuous heart monitoring technology used by physicians.

• Biotricity Releases Fiscal 2022 Second Quarter Financial Results

  11/4/2021

  Biotricity Inc. today announced financial results for its 2022 fiscal year's second quarter ended September 30, 2021.

• Biotricity to Report Second Quarter Fiscal 2022 Financial Results on November 4, 2021

  11/2/2021

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced that it will release its financial results for the second quarter ended September 30, 2021, on Thursday, November 4, 2021, after the close of the market.

• Biotricity to Discuss its Breakthrough Patient Monitoring Solutions at Virtual LD Micro Main Event XIV on Oct. 13th

  10/12/2021

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced that its Chief Executive Officer Waqaas Al Siddiq is scheduled to present in-person at the Virtual LD Micro Main Event XIV in-person on Wednesday, October 13, 2021 at 5:00 PM PT/ 8:00 PM ET.

• Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th

  10/6/2021

  Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced it will be ringing the Opening Bell on the Nasdaq Stock Market on Thursday, October 7, 2021 at 9:30am E.T.

• Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30

  9/28/2021

  Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced that its Chief Executive Officer Waqaas Al Siddiq is scheduled to present at the virtual Benzinga Healthcare Small Cap Conference on Thursday, September 30, 2021 at 12:15 p.m. ET.

• Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd

  9/21/2021

  Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced that its Chief Executive Officer Dr. Waqaas Al-Siddiq is scheduled to present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 22, 2021 at 2:55 p.m. ET.

• Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management

  9/14/2021

  Biotricity Inc. today announced that it has developed a personal medical device kit, Biokit, a bundled home-use set comprised of a digital thermometer, a pulse oximeter, and a blood pressure cuff.

• Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock

  9/13/2021

  Biotricity, Inc. today announced that the underwriter of its previously announced underwritten public offering which closed on August 30, 2021, has partially exercised its option to purchase additional shares of common stock at the public offering price, less underwriting discounts and commission.

• Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference

  9/8/2021

  Biotricity, Inc. today reported its CEO Waqaas Al-Siddiq is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference, which will be available on-demand starting at 7:00 a.m. ET on Monday, September 13, 2021.

• Biotricity Completes Nasdaq Listing

  8/30/2021

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced the closing of an underwritten public offering of 5,000,000 shares of common stock of the Company for total gross proceeds to the Company of approximately $15 million.

• Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market

  8/26/2021

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced the pricing of an underwritten public offering of 5,000,000 shares of common stock of the Company, at a price of $3.00 per share for total gross proceeds to the Company of approximately $15 million.

• Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing

  8/25/2021

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, announced that it intends to offer shares of its common stock for sale in an underwritten public offering.

• Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter

  8/16/2021

  Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, is pleased to provide financial results for its fiscal 2022 first quarter, which ended June 30, 2021.

• Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021

  8/12/2021

  Biotricity , Inc. today announced that it will release its financial results for the first quarter of fiscal 2022, ended June 30, 2021, on Monday, August 16, 2021, after the close of the market.

• Biotricity's 2021 Fiscal Fourth Quarter Growth Trend Continues into Fiscal 2022

  7/7/2021

  Biotricity, Inc. today announced preliminary revenue results guidance for its 2022 fiscal first quarter, ended June 30, 2021.

• Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021

  6/15/2021

  Biotricity, Inc. is pleased to provide unaudited, preliminary financial results for its fiscal 2021 fourth quarter and fiscal year, which ended March 31, 2021.

• Biotricity to Report Fourth Quarter Fiscal 2021 and Financial Results on June 15, 2021

  6/9/2021

  Biotricity, Inc. today announced that it will release its financial results for the fourth quarter and full fiscal year 2021, ended March 31, 2021, on Tuesday, June 15, 2021.

• Biotricity to Present at 2021 LD Micro Invitational XI

  6/1/2021

  Biotricity Inc. (OTCQB:BTCY) a medical diagnostic and consumer healthcare technology company, announced today that its CEO Waqaas Al-Siddiq will be presenting virtually at the upcoming LD Micro Invitational XI event on Tuesday, June 8, 2021, at 11:30 a.m. EDT (8:30 a.m. PDT).

• Biotricity Announces 2021 Uplisting Strategy to Major Exchange

  5/25/2021

  Biotricity, Inc. , a medical diagnostic and consumer healthcare technology company, is pleased to announce that it has begun executing on its strategy towards an uplist to a National Exchange in 2021. Waqaas Al-Siddiq, CEO of Biotricity previously mentioned this as a top priority for 2021.